1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. PIRAMAL PHARMA LTD.
Piramal Pharma Ltd.
NSE: PPLPHARMA | BSE: 543635
US FDA Inspections
Ask MarketMind AI
216.66 7.02 (3.35%)
4.4M
NSE+BSE Volume

NSE 20 Aug, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert

Piramal Pharma - PPLPHARMA - stock price prediction, stock forecast, target price, analyst ratings from 11 analysts

Piramal Pharma has a share price target of Rs 233, revenue growth forecast of 15.4%, and profit growth estimate of 158.5% for FY27, based on top 11 analyst calls.